Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Indomethacin 40 mg TID	93
Overall Study	STARTED	Indomethacin 40 mg BID	91
Overall Study	STARTED	Indomethacin 20 mg TID	91
Overall Study	STARTED	Celecoxib 200 mg	93
Overall Study	STARTED	Placebo	94
Overall Study	COMPLETED	Indomethacin 40 mg TID	90
Overall Study	COMPLETED	Indomethacin 40 mg BID	88
Overall Study	COMPLETED	Indomethacin 20 mg TID	89
Overall Study	COMPLETED	Celecoxib 200 mg	93
Overall Study	COMPLETED	Placebo	90
Overall Study	NOT COMPLETED	Indomethacin 40 mg TID	3
Overall Study	NOT COMPLETED	Indomethacin 40 mg BID	3
Overall Study	NOT COMPLETED	Indomethacin 20 mg TID	2
Overall Study	NOT COMPLETED	Celecoxib 200 mg	0
Overall Study	NOT COMPLETED	Placebo	4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01543685/flow